Development of a robotic 3D bioprinting and microfluidic pumping system for tissue and organ engineering

The technology of 3D bioprinting has gained significant interest in biomedical engineering, regenerative medicine, and the pharmaceutical industry. Providing a new scope in tissue and organ printing, 3D bioprinters are becoming commercialized for biological processes. However, the current technology is costly, ranging from USD9,000-0,000 and is limited to customized extrusion methods. Multiple microfluidic pump systems for bioink extrusion...